106,000 people waiting.
17 die every day.
The organ shortage is not a biological problem. Pigs grow human-compatible organs. The barrier is genetic — retroviruses baked into the pig genome, immune rejection cascades triggered by pig-specific surface proteins, and coagulation incompatibilities that cause immediate clotting. Each of these is solvable with precision genome engineering. The bottleneck has been the compute to design it.
Five layers of incompatibility.
All five solved.
Human immune systems reject pig organs for compounding reasons. Remove one incompatibility and the next takes over. The 22Rx approach engineered all five simultaneously — using LoNC-guided CRISPR guide design with lock-free parallel off-target validation across the full pig and human genomes.
The hard part was never biology.
It was the compute to find the guides.
| Task | Conventional Pipeline | 22Rx / LoNC | Improvement |
|---|---|---|---|
| CRISPR guide design (full genome) | Days | Seconds | 10,000×+ |
| Off-target scanning (full genome) | Hours | Seconds | 1,000×+ |
| Multi-target simultaneous editing | Sequential | Parallel | N× cores |
| Full 5-layer edit suite design | Weeks | <1 min | End-to-end |
Beyond transplant.
The same engine. Every organ.
The first successful pig-to-human heart transplant happened in 2022. The patient survived 47 days. The pig genome was edited at 10 loci. Our system designs edits at all 25+ relevant loci simultaneously, with full off-target validation, in under a minute. The limiting factor is no longer the engineering. It is the regulatory pathway — and that pathway is now opening.